Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

ABL‐N Induces Caspase‐dependent Apoptosis in Human Breast Cancer Cells Via Activation of C‐jun‐nh2‐terminal Kinase

ABL-N-induced Apoptosis in Human Breast Cancer Cells is Partially Mediated by C-Jun NH2-terminal Kinase Activation

AKT Inhibitor MK-2206 Sensitizes Breast Cancer Cells to MLN4924, a First-in-class NEDD8-activating Enzyme (NAE) Inhibitor

Bruceine D Induces Apoptosis in Human Non-Small Cell Lung Cancer Cells Through Regulating JNK Pathway

Sinomenine Enhanced Aclarubicin-Induced Apoptosis by Blocking Nf-Kappa B Pathway in Hl-60 Cells

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Down-regulation of Nicotinamide N-methyltransferase Induces Apoptosis in Human Breast Cancer Cells Via the Mitochondria-Mediated Pathway.

Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

ABL Kinases Promote Breast Cancer Osteolytic Metastasis by Modulating Tumor-Bone Interactions Through TAZ and STAT5 Signaling

Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells.

JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells.

Nodal and Activin Receptor-Like Kinase 7 Induce Apoptosis in Human Breast Cancer Cell Lines: Role of Caspase 3.

Apatinib-induced NF-κB Inactivation Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin.

Acetylbritannilactone suppresses growth via upregulation of krüppel-like transcription factor 4 expression in HT-29 colorectal cancer cells.

Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway

Abieslactone Induces Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinomas through the Mitochondrial Pathway and the Generation of Reactive Oxygen Species

Annonaceous Acetogenin Mimic AA005 Induces Cancer Cell Death Via Apoptosis Inducing Factor Through a Caspase-3-independent Mechanism

Acetylbritannilactone is a Potent Synergist of Celecoxib to Inhibit Cyclooxygenase‐2 Expression and to Induce Apoptosis in Human Breast Cancer Cells

Acetylbritannilactone Inhibits Smooth Muscle Cell Proliferation Through Suppression of Cell Cycle Progression, ERK1/2 Activation, and Induction of Apoptosis

Plumbagin from Plumbago Zeylanica L Induces Apoptosis in Human Non-small Cell Lung Cancer Cell Lines Through NF-κB Inactivation